In this video, I try to focus on the main lines of treatment and logisitics of care when dealing with an ACS patient in general, then give a little focus on the appropriate use of antiplatelets & anticoauglants in ACS (including STEMI & NSTE-ACS patients).
0:00 Intro & Agenda
01:38 General Lines of Treatment
12:42 Antithrombotic Therapy
2023 ESC Guidelines for the Management of Acute Coronary Syndromes
www.escardio.org/Guidelines/C...
2023 ESC Guidelines for the management of acute coronary syndromes Supplementary data
oup.silverchair-cdn.com/oup/b...
ISAR-REACT 5 trial. Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
pubmed.ncbi.nlm.nih.gov/31475...
ACCOAST trial. Pretreatment with Prasugrel in Non-ST-Segment Elevation Acute Coronary Syndromes
www.nejm.org/doi/full/10.1056...
DUBIUS trial. Timing of Oral P2Y12 Inhibitor Administration in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome
pubmed.ncbi.nlm.nih.gov/32882...
OASIS-5 trial. Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes
www.nejm.org/doi/pdf/10.1056/...
OASIS-6 trial. Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction.
jamanetwork.com/journals/jama...
OASIS-5 and OASIS-6 Trials Combined Analysis - OASIS-5 and OASIS-6 Trials Combined Analysis
www.acc.org/Latest-in-Cardiol...
ATLANTIC trial. Prehospital Ticagrelor in ST-Segment Elevation Myocardial Infarction
www.nejm.org/doi/full/10.1056...
Негізгі бет 2. Treatment of ACS-Part 1 (General Lines & Antithrombotic Therapy, Arabic Version)
Пікірлер: 10